Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission

Bone Marrow Transplant. 2016 Apr;51(4):610-1. doi: 10.1038/bmt.2015.305. Epub 2015 Dec 14.

Authors

A Ruggeri¹, M Labopin^{1

2}, F Ciceri³, M Mohty^{1

2}, A Nagler^{2

4}

Affiliations

¹ Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
² Université Pierre et Marie Curie, Paris, France.
³ Unità di Ematologia e trapianto di midollo, Ospedale San Raffaele, Milano, Italia.
⁴ Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

PMID: 26657834
DOI: 10.1038/bmt.2015.305

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Allografts
Disease-Free Survival
Female
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / mortality
Leukemia, Myeloid, Acute* / therapy
Male
Middle Aged
Survival Rate